Insider Transactions in Q2 2023 at Nutex Health, Inc. (NUTX)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+18.26%
|
$0
$0.42 P/Share
|
|
Jun 14
2023
|
Mitchell Creem Director |
BUY
Open market or private purchase
|
Indirect |
50,000
+37.95%
|
$0
$0.43 P/Share
|
|
Jun 14
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Open market or private purchase
|
Direct |
12,000
+29.63%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Cheryl Yvonne Grenas Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
Jun 13
2023
|
Michael Lee Reed Director |
BUY
Open market or private purchase
|
Indirect |
10,000
+50.0%
|
$0
$0.43 P/Share
|
|
May 26
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
18,028
+0.01%
|
$0
$0.49 P/Share
|
|
May 25
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
482,088
+0.18%
|
$0
$0.49 P/Share
|
|
May 19
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
385,000
+0.14%
|
$0
$0.58 P/Share
|
|
May 18
2023
|
Thomas T. Vo Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
114,884
+0.04%
|
$0
$0.48 P/Share
|
|
May 18
2023
|
John J Waters Director |
BUY
Open market or private purchase
|
Direct |
50,000
+20.3%
|
$0
$0.47 P/Share
|
|
Apr 01
2023
|
Jon Christian Bates Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
69,505
+36.17%
|
-
|
|
Apr 01
2023
|
Pamela W. Montgomery Chief Legal Officer-Healthcare |
BUY
Exercise of conversion of derivative security
|
Direct |
16,502
+50.0%
|
-
|